3M CO (MMM) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Marketable Securities, Current · Available-for-sale Securities, Current · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 11.38B USD | Liabilities, Current |
| Cash and equivalents | (m) | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Marketable Securities, Current · Available-for-sale Securities, Current |
| Customer receivables | 3.93B USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 3.77B USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $11.38B | (m) | (m) | $3.93B | $3.77B | (m) |
| 2026-03-31 | (m) | $9.03B | (m) | (m) | $3.75B | $3.69B | (m) |
| 2025-12-31 | (m) | $9.60B | (m) | (m) | $3.53B | $3.66B | (m) |
| 2025-09-30 | (m) | $8.73B | (m) | (m) | $3.78B | $3.89B | (m) |
| 2025-06-30 | (m) | $7.81B | (m) | (m) | $3.76B | $4.08B | (m) |
| 2025-03-31 | (m) | $9.45B | (m) | (m) | $3.50B | $3.87B | (m) |
| 2024-12-31 | (m) | $11.26B | (m) | (m) | $3.19B | $3.70B | (m) |
| 2024-09-30 | (m) | $11.39B | (m) | (m) | $3.53B | $4.04B | (m) |
| 2024-06-30 | (m) | $14.35B | (m) | (m) | $3.58B | $4.06B | (m) |
| 2024-03-31 | (m) | $13.16B | (m) | (m) | $4.75B | $4.90B | (m) |
| 2023-12-31 | (m) | $15.30B | (m) | (m) | $4.75B | $4.82B | (m) |
| 2023-09-30 | (m) | $15.47B | (m) | (m) | $4.85B | $5.07B | (m) |
| 2023-06-30 | (m) | $10.94B | (m) | (m) | $4.95B | $5.28B | (m) |
| 2023-03-31 | (m) | $10.56B | (m) | (m) | $4.64B | $5.31B | (m) |
| 2022-12-31 | (m) | $9.52B | (m) | (m) | $4.53B | $5.37B | (m) |
| 2022-09-30 | (m) | $9.54B | (m) | (m) | $4.72B | $5.62B | (m) |
| 2022-06-30 | (m) | $9.90B | (m) | (m) | $4.91B | $5.64B | (m) |
| 2022-03-31 | (m) | $9.15B | (m) | (m) | $4.82B | $5.29B | (m) |
| 2021-12-31 | (m) | $9.04B | (m) | (m) | $4.66B | $4.99B | (m) |
| 2021-09-30 | (m) | $9.63B | (m) | (m) | $4.92B | $4.95B | (m) |
| 2021-06-30 | (m) | $9.44B | (m) | $805.00M | $4.99B | $4.84B | (m) |
| 2021-03-31 | (m) | $8.36B | (m) | $501.00M | $4.82B | $4.46B | (m) |
| 2020-12-31 | (m) | $7.95B | (m) | $404.00M | $4.71B | $4.24B | (m) |
| 2020-09-30 | (m) | $7.41B | (m) | $440.00M | $4.62B | $3.98B | (m) |
| 2020-06-30 | (m) | $7.28B | (m) | $247.00M | $4.46B | $4.17B | (m) |
| 2020-03-31 | (m) | $9.13B | (m) | $224.00M | $4.82B | $4.22B | (m) |
| 2019-12-31 | (m) | $9.22B | (m) | $98.00M | $4.79B | $4.13B | (m) |
| 2019-09-30 | (m) | $7.82B | (m) | $30.00M | $5.02B | $4.01B | (m) |
| 2019-06-30 | (m) | $7.26B | (m) | $139.00M | $5.37B | $4.30B | (m) |
| 2019-03-31 | (m) | $7.13B | (m) | $539.00M | $5.17B | $4.54B | (m) |
| 2018-12-31 | (m) | $7.24B | (m) | $380.00M | $5.02B | $4.37B | (m) |
| 2018-09-30 | (m) | $7.34B | (m) | $338.00M | $5.33B | $4.44B | (m) |
| 2018-06-30 | (m) | $8.90B | (m) | $385.00M | $5.38B | $4.24B | (m) |
| 2018-03-31 | (m) | $8.96B | (m) | $604.00M | $5.25B | $4.29B | (m) |
| 2017-12-31 | (m) | $7.69B | (m) | $1.08B | $4.91B | $4.03B | (m) |
| 2017-09-30 | (m) | $6.60B | (m) | $586.00M | $5.16B | $3.98B | (m) |
| 2017-06-30 | (m) | $5.70B | (m) | $140.00M | $4.92B | $3.84B | (m) |
| 2017-03-31 | $7.04B | $6.00B | $2.17B | $141.00M | $4.72B | $3.61B | 1.17× |
| 2016-12-31 | $7.07B | $6.22B | $2.40B | $280.00M | $4.39B | $3.38B | 1.14× |
| 2016-09-30 | $7.41B | $6.40B | $2.31B | $358.00M | $4.74B | $3.61B | 1.16× |
| 2016-06-30 | $6.53B | $7.25B | $1.69B | $177.00M | $4.67B | $3.61B | 0.90× |
| 2016-03-31 | $6.00B | $7.18B | $1.34B | $176.00M | $4.49B | $3.63B | 0.84× |
| 2015-12-31 | $6.07B | $7.12B | $1.80B | $118.00M | $4.15B | $3.52B | 0.85× |
| 2015-09-30 | $6.37B | $7.03B | $1.60B | $153.00M | $4.61B | $3.71B | 0.91× |
| 2015-06-30 | $8.06B | $5.09B | $2.98B | $502.00M | $4.58B | $3.85B | 1.58× |
| 2015-03-31 | $7.22B | $5.08B | $1.79B | $1.02B | $4.41B | $3.70B | 1.42× |
| 2014-12-31 | $6.76B | $6.00B | $1.90B | $626.00M | $4.24B | $3.71B | 1.13× |
| 2014-09-30 | $7.41B | $7.71B | $1.93B | $767.00M | $4.71B | $3.94B | 0.96× |
| 2014-06-30 | $7.77B | $7.04B | $2.13B | $884.00M | $4.76B | $4.09B | 1.10× |
| 2014-03-31 | $7.41B | $7.45B | $1.95B | $860.00M | $4.60B | $3.97B | 0.99× |
| 2013-12-31 | $7.59B | $7.50B | $2.58B | $756.00M | $4.25B | $3.86B | 1.01× |
| 2013-09-30 | $7.91B | $7.44B | $2.34B | $971.00M | $4.59B | $3.95B | 1.06× |
| 2013-06-30 | $8.79B | $6.33B | $2.94B | $1.31B | $4.54B | $3.92B | 1.39× |
| 2013-03-31 | $8.79B | $5.94B | $2.93B | $1.45B | $4.42B | $3.82B | 1.48× |
| 2012-12-31 | $8.59B | $6.20B | $2.88B | $1.65B | $4.06B | $3.84B | 1.39× |
| 2012-09-30 | $9.43B | $6.59B | $3.03B | $1.99B | $4.41B | $3.84B | 1.43× |
| 2012-06-30 | $9.27B | $5.71B | $3.31B | $1.59B | $4.36B | $3.66B | 1.62× |
| 2012-03-31 | $8.05B | $5.41B | $2.33B | $1.40B | $4.32B | $3.56B | 1.49× |
| 2011-12-31 | $7.55B | $5.44B | $2.22B | $1.46B | $3.87B | $3.42B | 1.39× |
| 2011-09-30 | $9.12B | $6.17B | $3.38B | $1.49B | $4.26B | $3.60B | 1.48× |
| 2011-06-30 | $8.91B | $6.20B | $3.38B | $1.15B | $4.38B | $3.72B | 1.44× |
| 2011-03-31 | $8.24B | $5.90B | $2.75B | $1.28B | $4.21B | $3.49B | 1.40× |
| 2010-12-31 | $8.09B | $6.09B | $3.38B | $1.10B | $3.62B | $3.15B | 1.33× |
| 2010-09-30 | $9.72B | $5.39B | $4.47B | $1.39B | $3.87B | $3.21B | 1.80× |
| 2010-06-30 | $8.68B | $5.44B | $3.02B | $1.91B | $3.75B | $2.98B | 1.60× |
| 2010-03-31 | $8.18B | $5.15B | $2.85B | $1.76B | $3.57B | $2.80B | 1.59× |
| 2009-12-31 | $7.03B | $4.90B | $3.04B | $744.00M | $3.25B | $2.64B | 1.44× |
| 2009-09-30 | $7.57B | $5.77B | $3.24B | $697.00M | $3.64B | $2.63B | 1.31× |
| 2009-06-30 | $6.43B | $5.32B | $2.60B | $378.00M | $3.46B | $2.60B | 1.21× |
| 2009-03-31 | (m) | (m) | $1.63B | (m) | (m) | (m) | (m) |
| 2008-12-31 | $5.42B | $5.84B | $1.85B | $373.00M | $3.19B | $3.01B | 0.93× |
| 2008-09-30 | (m) | (m) | $2.24B | (m) | (m) | (m) | (m) |
| 2008-06-30 | (m) | (m) | $1.55B | (m) | (m) | (m) | (m) |
| 2007-12-31 | (m) | (m) | $1.90B | (m) | (m) | (m) | (m) |
| 2006-12-31 | (m) | (m) | $1.45B | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |